Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma.

Wu J, Contratto M, Shanbhogue KP, Manji GA, O'Neil BH, Noonan A, Tudor R, Lee R.

World J Clin Oncol. 2019 Mar 24;10(3):149-160. doi: 10.5306/wjco.v10.i3.149.

2.

Neoadjuvant Treatment for Pancreatic Cancer.

Raufi AG, Manji GA, Chabot JA, Bates SE.

Semin Oncol. 2019 Feb;46(1):19-27. doi: 10.1053/j.seminoncol.2018.12.002. Epub 2018 Dec 28. Review.

PMID:
30630600
3.

Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.

Yeh CC, Goyal A, Shen J, Wu HC, Strauss JA, Wang Q, Gurvich I, Safyan RA, Manji GA, Gamble MV, Siegel AB, Santella RM.

Ann Surg Oncol. 2017 Nov;24(12):3788-3795. doi: 10.1245/s10434-017-5913-4. Epub 2017 Jun 7.

4.

Current and Emerging Therapies in Metastatic Pancreatic Cancer.

Manji GA, Olive KP, Saenger YM, Oberstein P.

Clin Cancer Res. 2017 Apr 1;23(7):1670-1678. doi: 10.1158/1078-0432.CCR-16-2319. Review.

5.

Dose-finding designs for trials of molecularly targeted agents and immunotherapies.

Chiuzan C, Shtaynberger J, Manji GA, Duong JK, Schwartz GK, Ivanova A, Lee SM.

J Biopharm Stat. 2017;27(3):477-494. doi: 10.1080/10543406.2017.1289952. Epub 2017 Feb 6.

6.

Managing Liposarcomas: Cutting Through the Fat.

Manji GA, Schwartz GK.

J Oncol Pract. 2016 Mar;12(3):221-7. doi: 10.1200/JOP.2015.009860. Review.

PMID:
26962163
7.

Immune Targeting in Gastrointestinal Malignancies: Finding the Right Combination for the Right Site.

Manji GA.

Oncology (Williston Park). 2016 Jan;30(1):91-3. No abstract available.

8.

Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.

Tallman MS, Manji GA.

Blood Cells Mol Dis. 2011 Feb 15;46(2):173-4. doi: 10.1016/j.bcmd.2010.12.001. Epub 2011 Jan 11. No abstract available.

PMID:
21227722
9.

Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1.

Grenier JM, Wang L, Manji GA, Huang WJ, Al-Garawi A, Kelly R, Carlson A, Merriam S, Lora JM, Briskin M, DiStefano PS, Bertin J.

FEBS Lett. 2002 Oct 23;530(1-3):73-8.

10.

PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing.

Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS, Bertin J.

J Biol Chem. 2002 Aug 16;277(33):29874-80. Epub 2002 May 17.

11.

PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B.

Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al-Garawi A, Mak S, Lora JM, Briskin M, Jurman M, Cao J, DiStefano PS, Bertin J.

J Biol Chem. 2002 Mar 29;277(13):11570-5. Epub 2002 Jan 10.

12.

Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis.

Geddes BJ, Wang L, Huang WJ, Lavellee M, Manji GA, Brown M, Jurman M, Cao J, Morgenstern J, Merriam S, Glucksmann MA, DiStefano PS, Bertin J.

Biochem Biophys Res Commun. 2001 Jun 1;284(1):77-82.

PMID:
11374873
13.

Apoptosis in motion. An apical, P35-insensitive caspase mediates programmed cell death in insect cells.

Manji GA, Friesen PD.

J Biol Chem. 2001 May 18;276(20):16704-10. Epub 2001 Feb 23.

14.

Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.

Wang L, Guo Y, Huang WJ, Ke X, Poyet JL, Manji GA, Merriam S, Glucksmann MA, DiStefano PS, Alnemri ES, Bertin J.

J Biol Chem. 2001 Jun 15;276(24):21405-9. Epub 2001 Mar 20.

15.
16.
17.

Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.

Ehlers MR, Schwager SL, Scholle RR, Manji GA, Brandt WF, Riordan JF.

Biochemistry. 1996 Jul 23;35(29):9549-59.

PMID:
8755736

Supplemental Content

Loading ...
Support Center